Updates in hypertrophic cardiomyopathy care: Bridging the current treatment gaps with emerging novel therapies

touchEXPERT FOCUS for touchCARDIO

Listen to short interviews with two expert cardiologists discussing the role of current and emerging therapeutic classes that aim to address the unmet needs of patients with hypertrophic cardiomyopathy. The faculty will review current therapeutic approaches for managing obstructive versus nonobstructive hypertrophic cardiomyopathy to highlight existing gaps in patient care. They will then discuss the latest data for emerging therapeutic classes and consider how they may address patients’ unmet needs in the future.   

The experts

• Dr Martin Maron, Lahey Hospital & Medical Center, Burlington, MA, USA
• Dr Michelle Michels, Erasmus MC, Rotterdam, The Netherlands

This touchPODCAST is for healthcare professionals outside of the UK.

This activity is supported by an independent medical educational grant from Cytokinetics, Inc.

Jointly provided by Partners for Advancing Clinical Education and touchIME.
touchIME is an EBAC® accredited provider.

For further information visit our website: 

https://touchcardio.com/